These findings propose novel therapeutic strategies for the management of sepsis, including targeting IGF2-AS as a potential therapeutic intervention and considering the modulation of dNTP concentrations to regulate sepsis pathogenesis [78]. The gene discussed is IGF2-AS; the disease is Sepsis.